Dengue virus serotyping is crucial for clinical management and epidemiology of the disease. As serotype shifts and secondary infection with a heterologous DENV serotype are frequently associated with disease severity, there is a need for sustained monitoring of the circulating serotypes and enhanced surveillance operations to prevent large scale severe dengue outbreaks. Our main objective is to know the serologically laboratory confirmed dengue cases (by NS1 antigen detection ELISA) among the clinically suspected patients and to correlate the above with the prevalent serotype based on real time RT-PCR. |
